Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
VNDA on Nasdaq
Shares outstanding
59,964,750
Price per share
$8.82
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
44,907,654
Total reported value
$224,087,389
% of total 13F portfolios
0%
Share change
-154,124
Value change
-$589,252
Number of holders
147
Price from insider filings
$8.82
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.1% -47% $20,206,904 -$18,941,173 4,699,280 -48% BlackRock, Inc. 31 Jan 2025
BlackRock Portfolio Management LLC 7.7% $19,260,070 4,479,086 BlackRock Portfolio Management LLC 31 Mar 2025
MILLENNIUM MANAGEMENT LLC 2.8% -50% $14,808,391 -$12,712,063 1,679,013 -46% Millennium Management LLC 31 Dec 2025

As of 30 Sep 2025, 147 institutional investors reported holding 44,907,654 shares of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA). This represents 75% of the company’s total 59,964,750 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) together control 64% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 15% 8,918,305 -5.5% 0% $44,502,342
VANGUARD GROUP INC 6% 3,587,139 +0.4% 0% $17,899,824
RENAISSANCE TECHNOLOGIES LLC 5.8% 3,476,925 +0.85% 0.02% $17,349,856
MILLENNIUM MANAGEMENT LLC 5.4% 3,250,836 +4.2% 0.01% $16,221,672
DIMENSIONAL FUND ADVISORS LP 4.3% 2,563,969 -0.84% 0% $12,793,562
TANG CAPITAL MANAGEMENT LLC 3.9% 2,353,307 0% 0.45% $11,743,002
ACADIAN ASSET MANAGEMENT LLC 3.7% 2,228,744 +29% 0.02% $11,115,000
GEODE CAPITAL MANAGEMENT, LLC 2.3% 1,392,085 -18% 0% $6,948,196
STATE STREET CORP 2.1% 1,271,079 +0.41% 0% $6,342,684
Krensavage Asset Management, LLC 2% 1,180,388 +15% 2.5% $5,890,000
TWO SIGMA ADVISERS, LP 1.5% 909,300 +12% 0.01% $4,537,407
Connor, Clark & Lunn Investment Management Ltd. 1.5% 904,544 +4.2% 0.01% $4,513,675
Empire Financial Management Company, LLC 1.3% 758,091 +289% 0.87% $3,782,874
FEDERATED HERMES, INC. 1.1% 681,836 -6.4% 0.01% $3,402,362
AQR CAPITAL MANAGEMENT LLC 1.1% 668,466 +393% 0% $3,335,646
TWO SIGMA INVESTMENTS, LP 1.1% 662,305 +26% 0.01% $3,304,902
MORGAN STANLEY 1.1% 637,499 -29% 0% $3,181,120
MARSHALL WACE, LLP 0.97% 581,247 +23% 0% $2,900,421
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.82% 488,936 +8.6% 0% $2,439,791
NORTHERN TRUST CORP 0.76% 454,572 -0.99% 0% $2,268,314
PRUDENTIAL FINANCIAL INC 0.75% 449,403 -26% 0% $2,242,521
GOLDMAN SACHS GROUP INC 0.57% 339,701 -16% 0% $1,695,108
GSA CAPITAL PARTNERS LLP 0.53% 318,799 -17% 0.13% $1,591,000
CITADEL ADVISORS LLC 0.44% 263,806 +78% 0% $1,316,392
Monaco Asset Management SAM 0.41% 247,805 -19% 0.46% $1,236,547

Institutional Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 42,425 $357,717 -$765,267 $8.82 7
2025 Q3 44,907,654 $224,087,389 -$589,252 $4.99 147
2025 Q2 45,005,222 $212,432,729 +$5,358,364 $4.72 137
2025 Q1 43,925,314 $201,682,351 +$2,283,938 $4.59 145
2024 Q4 43,147,771 $206,663,421 -$5,834,005 $4.79 146
2024 Q3 43,981,766 $206,261,308 +$385,141 $4.69 151
2024 Q2 43,532,710 $245,988,772 -$20,221,284 $5.65 147
2024 Q1 48,062,202 $197,420,430 -$11,386,730 $4.11 140
2023 Q4 50,696,953 $213,770,549 -$8,165,025 $4.22 154
2023 Q3 52,588,884 $227,183,918 -$23,037,768 $4.32 179
2023 Q2 56,248,075 $370,694,666 -$14,253,028 $6.59 187
2023 Q1 58,308,583 $395,914,559 +$17,232,279 $6.79 176
2022 Q4 55,589,814 $410,808,616 +$2,189,163 $7.39 186
2022 Q3 55,141,714 $544,810,424 -$11,288,828 $9.88 171
2022 Q2 56,006,392 $610,516,173 -$187,164 $10.90 166
2022 Q1 56,272,506 $636,565,420 +$17,401,270 $11.31 181
2021 Q4 54,252,447 $851,181,026 -$29,760,480 $15.69 192
2021 Q3 55,224,691 $946,649,896 +$4,381,069 $17.14 173
2021 Q2 54,791,110 $1,178,013,080 +$10,402,309 $21.51 176
2021 Q1 54,541,422 $819,510,471 -$4,488,836 $15.02 182
2020 Q4 55,039,795 $723,395,120 +$5,524,875 $13.14 170
2020 Q3 54,414,204 $525,712,121 -$8,605,614 $9.66 159
2020 Q2 55,140,491 $630,777,920 +$15,624,266 $11.44 159
2020 Q1 53,776,502 $557,290,753 +$129,584 $10.36 154
2019 Q4 52,825,174 $866,806,457 -$1,382,881 $16.41 170
2019 Q3 52,964,599 $703,437,080 -$21,562,526 $13.28 161
2019 Q2 54,287,178 $764,978,865 +$13,754,283 $14.09 158
2019 Q1 54,377,164 $1,000,565,489 +$5,340,845 $18.40 175
2018 Q4 53,011,338 $1,384,693,451 +$27,801,917 $26.13 180
2018 Q3 52,207,975 $1,198,127,037 +$80,020,008 $22.95 157
2018 Q2 49,022,523 $933,879,055 +$18,597,031 $19.05 134
2018 Q1 48,202,587 $812,206,007 +$128,627,396 $16.85 130
2017 Q4 40,872,797 $621,278,889 +$12,023,355 $15.20 125
2017 Q3 39,724,724 $711,076,419 +$17,158,833 $17.90 137
2017 Q2 38,857,064 $633,364,808 -$6,543,528 $16.30 131
2017 Q1 39,704,878 $555,846,956 +$44,096,425 $14.00 134
2016 Q4 40,641,934 $648,300,745 -$10,229,525 $15.95 141
2016 Q3 40,758,505 $678,216,752 +$66,622,806 $16.64 137
2016 Q2 37,247,837 $416,814,941 -$42,220,720 $11.19 115
2016 Q1 41,259,486 $344,882,956 -$12,846,699 $8.36 115
2015 Q4 42,551,919 $396,337,229 -$31,495,959 $9.31 116
2015 Q3 42,714,610 $481,809,118 +$465,619 $11.28 121
2015 Q2 42,413,548 $538,068,965 -$35,411,925 $12.69 109
2015 Q1 46,293,079 $430,514,637 -$27,508,593 $9.30 108
2014 Q4 47,666,210 $682,064,306 +$77,111,645 $14.32 108
2014 Q3 41,299,517 $428,691,693 +$24,205,345 $10.38 101
2014 Q2 38,482,247 $622,313,434 +$52,888,872 $16.18 110
2014 Q1 35,159,995 $571,479,438 +$57,348,441 $16.25 109